Beyond the Rash: Emerging Innovation Fuels a New Era in Dermatomyositis Therapy

Retrieved on: 2025-06-09 21:58:44

Tags for this article:

Autoimmune diseases

Immunology

Dermatomyositis

Neonatal fragment crystallizable receptor

CAR T cell

Autoimmunity

Click the tags to see associated articles and topics

Beyond the Rash: Emerging Innovation Fuels a New Era in Dermatomyositis Therapy. View article details on hiswai:

Excerpt

... monoclonal antibody targeting the Type I interferon receptor (IFNAR1). ... - Daxdilimab (Amgen) and Empasiprubart (argenx): Novel monoclonal antibodies ...

Article found on: rivercountry.newschannelnebraska.com

View Original Article